aTyr Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	10.01	10.74	11.06	22.54	9.98	2.34
Short-Term Investments	56.51	67.94	61.07	75.62	56.17	105.58
Cash & Short-Term Investments	66.51	78.69	72.13	98.17	66.15	107.91
Cash Growth	-12.88%	9.10%	-26.53%	48.41%	-38.70%	240.53%
Other Receivables	0.48	0.87	1.74	2.44	11.78	0.44
Total Trade Receivables	0.48	0.87	1.74	2.44	11.78	0.44
Other Current Assets	0.59	0.68	8.09	2.39	2.95	5.22
Total Current Assets	67.58	80.24	81.95	102.99	80.87	113.57
Net Property, Plant & Equipment	10.13	10.38	11.86	14.05	11.56	1.81
Other Long-Term Assets	1.95	2.38	3.02	3.62	3.36	0.16
Total Assets	79.65	93	96.83	120.65	95.79	115.54
Accounts Payable	2.76	3.89	4.32	3.53	3.11	1.03
Accrued Expenses	7.46	9.79	9.39	11.56	9.86	4
Current Portion of Leases	1.49	1.47	1.25	1.33	0.89	0.98
Total Current Liabilities	11.7	15.15	14.97	16.42	13.86	6.01
Long-Term Leases	10.21	10.57	12.03	13.77	10.64	0.4
Total Long-Term Liabilities	10.21	10.57	12.03	13.77	10.64	0.4
Total Liabilities	21.91	25.72	27	30.18	24.5	6.41
Common Stock	0.1	0.1	0.08	0.06	0.03	0.03
Additional Paid-in Capital	674.86	673.55	602.02	558.69	489.5	481.83
Accumulated Other Comprehensive Income	-0.07	-0.01	-0.04	-0.07	-0.43	-0.26
Retained Earnings	-616.96	-606.16	-532.05	-468.02	-417.63	-372.3
Total Common Shareholders' Equity	57.93	67.48	70.02	90.66	71.46	109.3
Minority Interest	-0.19	-0.19	-0.19	-0.19	-0.18	-0.18
Shareholders' Equity	57.74	67.29	69.83	90.47	71.28	109.13
Total Liabilities & Equity	79.65	93	96.83	120.65	95.79	115.54
Total Debt	11.7	12.03	13.28	15.1	11.53	1.38
Net Cash (Debt)	54.81	66.65	58.84	83.07	54.61	106.53
Net Cash Growth	-17.77%	13.28%	-29.17%	52.11%	-48.74%	261.74%
Net Cash Per Share	0.57	0.72	0.79	1.55	1.92	5.58
Book Value	57.93	67.48	70.02	90.66	71.46	109.3
Book Value Per Share	0.60	0.73	0.94	1.69	2.51	5.73
Tangible Book Value	57.93	67.48	70.02	90.66	71.46	109.3
Tangible Book Value Per Share	0.60	0.73	0.94	1.69	2.51	5.73

SEC Filings: 10-K · 10-Q